OncoMatch/Clinical Trials/NCT06161207

3D-4K-ICG Laparoscopic Gastrectomy for Gastric Cancer

Is NCT06161207 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for gastric cancer.

Phase 3RecruitingFujian Medical UniversityNCT06161207Data as of May 2026

Patients with locally advanced gastric adenocarcinoma (CT2-4a N-/+ M0) were selected as study subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging tracing in 3D plus ultra high resolution laparoscopic gastrectomy with lymph node dissection for gastric cancer.

Check if I qualify

Extracted eligibility criteria

Cancer type

Gastric Cancer

Disease stage

Required: Stage CT2-4A, N-/+ (AJCC Cancer Staging Manual, 8th Edition)

cT2-4a, N-/+, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual, 8th Edition

Performance status

ECOG 0–1(Restricted strenuous activity)

Prior therapy

No prior treatment (treatment-naive required)

Cannot have received: neoadjuvant chemotherapy

Cannot have received: neoadjuvant radiotherapy

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify